PanDx raises seed investment to develop a versatile catheter to treat severe GI conditions
RBV Capital (backed by Alexey Repik’s R-Pharmand RVC) invested RUB 105 million (ca. $1.5M) in PanDx, a UK-based company developing a novel catheter to treat acute pancreatitis and other severe conditions of the gastrointestinal tract (GI).